A record of what CA Rudramurthy BV said publicly, with the source. Not advice.
Pending — not yet graded
“Considers Pharma one of the best 'go-to' sectors, highlighting Divi’s Labs, Laurus Labs, and Biocon as very attractive stock picks within the sector.”
CA Rudramurthy BV’s track record (trackable calls only): 33 graded calls · 95% CI 27–59%
Nifty PharmaBullishCalled 04 Jul 2025
How this relative call is judged
A relative call is a comparison, judged on closing prices from the first close after the call to the end of its window (3 months when the quote states no time frame). The spread is the pick's return minus the comparator's return: above zero is a hit for a call that favours the pick, and the reverse for a call that marks it down.
Window still open: no verdict until it ends.
This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.
Read the original articleSee CA Rudramurthy BV’s full track record